Garcia-Gomez, Antonio <br/><br/>
Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects.  [electronic resource] 

 -  PloS one  2012 
 - e34914 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0034914  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anabolic Agents--pharmacology<br/>Animals<br/>Bone Remodeling--drug effects<br/>Bone Resorption--metabolism<br/>CSK Tyrosine-Protein Kinase<br/>Cathepsin K--metabolism<br/>Cell Differentiation--drug effects<br/>Cell Line<br/>Cell Proliferation--drug effects<br/>Dasatinib<br/>Female<br/>Humans<br/>Integrin alphaVbeta3--metabolism<br/>Leukocytes, Mononuclear--cytology<br/>Mesenchymal Stem Cells--cytology<br/>Mice<br/>NFATC Transcription Factors--metabolism<br/>Osteoclasts--cytology<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Serine-Threonine Kinases--metabolism<br/>Protein-Tyrosine Kinases--metabolism<br/>Proto-Oncogene Proteins c-kit--metabolism<br/>Pyrimidines--pharmacology<br/>Receptor, Platelet-Derived Growth Factor beta--antagonists & inhibitors<br/>Thiazoles--pharmacology<br/>Wnt Signaling Pathway<br/>src-Family Kinases